CTEG: How do I communicate where I’m at in the clinical translation continuum?

A presentation by Mary Sunderland, PhD (Foundation Fighting Blindness) and Dawn Richards, PhD (Clinical Trials Ontario) at the Bench to Bedside for Biotherapeutics (B3) Workshop held in Toronto on October 5, 2017.

A candid discussion with Dawn Richards from Clinical Trials Ontario talking about the importance of how communicating with patients and key stakeholder along the clinical pipeline in invaluable for clinical adaption. Speaking as both a patient advocate and through her role with CTO, Dawn Richards has a unique and important perspective for researchers.

This video is presented by the Clinical Translation Education Group: BioCanRx, CCRM, CellCAN, Foundation Fighting Blindness, Ontario Institute for Cancer Research, Ontario Institute for Regenerative Medicine and Stem Cell Network.

MaRS Centre, West Tower
661 University Avenue, Suite 1002
Toronto, Ontario M5G 1M1 Canada
t: 416-978-3751
f: 416-978-1368

We wish to acknowledge this land on which CCRM operates. For thousands of years, it has been the traditional land of the Huron-Wendat, the Seneca, and the Mississaugas of the Credit. Today, this meeting place is still the home to many Indigenous people from across Turtle Island and we are grateful to have the opportunity to work on this land.